Evidence map›Paper›PMID 30231777›Full record

ReviewExpert review of endocrinology & metabolism2018

Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms.

William P Martin, Neil G Docherty, Carel W Le Roux

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of endocrinology & metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Comment on: Impact of serum uric acid on renal function after bariatric surgery: a retrospective study.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 3 countries.

William P Martina Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine , University College Dublin , Dublin , Ireland.ORCID 0000-0001-7005-3966
Neil G Dochertya Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine , University College Dublin , Dublin , Ireland.ORCID 0000-0002-0961-2607
Carel W Le Rouxa Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine , University College Dublin , Dublin , Ireland.ORCID 0000-0001-5521-5445
University College Dublin · IE

Funding

Wellcome Trust 203930Wellcome Trust 203930/B/16/Z
6 · The paper itself

Abstract

introductionCardiovascular and renal disease accounts for a substantial proportion of the morbidity and mortality associated with obesity and type 2 diabetes mellitus (T2DM). Bariatric surgery is associated with improved long-term cardiovascular and renal outcomes. AREAS COVERED: All major case-control, cohort, and randomized controlled trial studies of bariatric surgery in adults with T2DM were screened and data on prespecified cardiovascular and renal outcomes collated. Bariatric surgery reduces all-cause mortality and risk of cardiovascular disease, albuminuria and progressive chronic kidney disease. Patients with poorer glycemic control and established microvascular disease preoperatively may stand to benefit the most from the surgical approach. Reduced sympathetic drive, remission of glomerular hypertension, enhanced natriuresis, gut microbiota shifts, reduced systemic and renal inflammation, improved lipoprotein profiles, and reductions in chronic cardiac remodeling may all be implicated. EXPERT COMMENTARY: Ongoing RCTs of bariatric surgery selectively recruiting patients with class 1 obesity and established microvascular complications of diabetes will help to better characterize which subgroups of patients benefit most from this effective therapy.

Indexed as

Bariatric SurgeryDiabetic AngiopathiesDiabetic NephropathiesDiabetes Mellitus, Type 2HumansObesityalbuminuriaBariatric surgerycardiovascular diseasediabetic kidney diseasediabetic nephropathyhypertensionmetabolic surgeryobesitytype 2 diabetes mellitus

Identifiers

PMID30231777
PMCPMC6773600
OpenAlexW2889248067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.